Drug intelligence / Profile preview

Araniforce

Development stage: Unknown
Lead developer: Weber & Weber
Modality: Small Molecules
Administration: Oral

Overview

Araniforce is a homeopathic complex medication developed by Weber & Weber Biologische Arzneimittel, specifically indicated for the treatment of musculoskeletal conditions, including joint disorders and sports-related injuries. The formulation consists of a synergistic blend of botanical extracts in homeopathic dilutions, such as *Arnica montana*, *Calendula officinalis*, *Hamamelis virginiana*, and *Ruta graveolens*. It is traditionally used to alleviate pain, reduce inflammation, and support the healing of connective tissues and joints. As a natural medicine, it aims to stimulate the body's self-regulatory processes to manage symptoms of degenerative and inflammatory joint diseases, as well as acute trauma like sprains and contusions.

Brand names: Araniforce

Beyond the preview

Go deeper on Araniforce.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Araniforce.

Explore the full profile